|
March 2, 2005
|
Affinergy Selected to Present at CED Venture Capital Conference
Affinergy's "site-specific biological delivery system" to be featured on main stage of prestigious investor conference at Pinehurst.
RESEARCH TRIANGLE PARK, N.C., March 2, 2005 - Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, was selected by The Council for Entrepreneurial Development (CED) to present at Venture 2005. Scheduled for April 26-27, 2005, at Pinehurst Resort in Pinehurst, NC, CED's Venture 2005 conference will continue a 22-year tradition of showcasing North Carolina's innovation economy and leading investment opportunities.
"Affinergy is excited to present our commercial strategy to Venture 2005 attendees," said Peyton Anderson, chief executive officer of Affinergy. "We have made tremendous progress over the past twelve months in hitting our key technical milestones and building new customer relationships. We look forward to updating existing and prospective investors about our recent activities and future plans. In addition to the venture capitalists, we also look forward to meeting with the investment professionals of potential corporate partners."
"Affinergy has benefited greatly from numerous CED programs since our inception and is excited to accept this selection to Venture 2005," said Jonathan Gindes, vice president of operations and finance at Affinergy. "We have a focused set of milestones and deliverables for 2005 that our team is working towards. Affinergy is poised for a breakout year in 2005 and we look forward to building and expanding our partnerships with leading medical device and therapeutic companies."
Venture 2005 is the Southeast's most well-established venture financing conference. Presented by CED with support from UNC Kenan-Flagler Business School and the National Venture Capital Association, Venture 2005 will showcase North Carolina's leading early and later-stage companies to hundreds of venture capitalists and financiers from throughout the United States. Since 1999, Venture presenters have raised over $1.6 billion in venture capital.
For more information on the Venture 2005 selected companies, visit http://www.cednc.org/conferences/venture/2005/presenters.
About Affinergy, Inc.
Affinergy develops site-specific biological and drug delivery systems. We use biofriendly binders that can selectively adhere to proteins, drugs, cells, and other biomaterial surfaces in order to direct biology toward an intended outcome. Affinergy is primarily focused on orthopedic devices and delivering biological therapeutics with a growing interest in cardiovascular applications. Affinergy's technology was patented at Duke University and has been incubated at Becton Dickinson's research center in Research Triangle Park.
For more information, visit www.affinergy.com or contact Peyton Anderson at (919) 597-6227.
About CED
The Council for Entrepreneurial Development (www.cednc.org), located in Research Triangle Park, NC, is a private, non-profit organization formed in 1984 to stimulate the creation and growth of high-impact companies in the greater Research Triangle region. CED provides education, mentoring and capital formation resources to new and existing high-growth entrepreneurs through annual conferences, seminars, workshops and monthly programs on entrepreneurial management and finance. CED is the largest entrepreneurial support organization in the nation with more than 3,500 members representing 1,000 entrepreneurial companies, financiers and professional firms.
|
